Atlas Trials

Uma Borate

7 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Uma Borate

RecordFirmDate
Ziftomenib for the Treatment of Patients With NPM1 Mutated or KMT2A Rearranged Acute Myeloid Leukemia Not Eligible for Standard Therapy (NCT06930352)Uma Borate2026-09-10
SNDX-5613 and Gilteritinib for the Treatment of Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia and Concurrent MLL-Rearrangement or NPM1 Mutation (NCT06222580)Uma Borate2024-02-20
Canakinumab for the Prevention of Progression to Cancer in Patients With Clonal Cytopenias of Unknown Significance, IMPACT Study (NCT05641831)Uma Borate2023-02-06
Venetoclax and Azacitidine for Treatment of Therapy Related or Secondary Myelodysplastic Syndrome (NCT05379166)Uma Borate2022-06-23
TP-0903 for the Treatment of FLT3 Mutated Acute Myeloid Leukemia (NCT04518345)Uma Borate2020-11-05
Gentuzumab Ozogamicin and Midostaurin Combination With Standard Cytarabine and Danunorubi Midostaurin as a Novel Approach to Treating Patients With Newly Diagnosed FLT-3 Mutated Acute Myeloid Leukemia (NCT03900949)Uma Borate2019-03-13

Track Uma Borate automatically

Every clearance here is in the API, with alerts when new ones post.